Publications
Export 115 results:
Auteur Title Type [ Année
Filtres: Auteur is Pedro Rosa-Neto [Enlever les filtres]
18F-MK-6240 PET for early and late detection of neurofibrillary tangles.. Brain. 143(9):2818-2830.
.
2020. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer's disease.. Mol Psychiatry.
.
2020. .
2020. Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating.. J Clin Invest. 130(12):6616-6630.
.
2020. Cholinergic Modulation of Binocular Vision.. J Neurosci. 40(27):5208-5213.
.
2020. The effects of exercise on sleep quality in persons with Parkinson's disease: A systematic review with meta-analysis.. Sleep Med Rev. 55:101384.
.
2020. Frontal Variant of Alzheimer Disease Differentiated From Frontotemporal Dementia Using in Vivo Amyloid and Tau Imaging.. Cogn Behav Neurol. 33(4):288-293.
.
2020. Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future research.. Alzheimers Dement (N Y). 6(1):e12085.
.
2020. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper.. J Cereb Blood Flow Metab. 40(8):1576-1585.
.
2020. Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials.. Dement Geriatr Cogn Disord. 49(4):334-348.
.
2020. Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans.. J Psychiatry Neurosci. 45(4):190162.
.
2020. Morphometric network differences in ageing versus Alzheimer's disease dementia.. Brain. 143(2):635-649.
.
2020. Suicidal ideation is common in autosomal dominant Alzheimer's disease at-risk persons.. Int J Geriatr Psychiatry. 35(1):60-68.
.
2020. .
2020. Association of TLR4 with Alzheimer's disease risk and presymptomatic biomarkers of inflammation.. Alzheimers Dement. 15(7):951-960.
.
2019. Astrocyte Biomarkers in Alzheimer's Disease.. Trends Mol Med.
.
2019. Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression.. Nat Commun. 10(1):2240.
.
2019. Constrained instruments and their application to Mendelian randomization with pleiotropy.. Genet Epidemiol.
.
2019. First-in-Human Brain Imaging of [F]TRACK, a PET tracer for Tropomyosin Receptor Kinases.. ACS Chem Neurosci. 10(6):2697-2702.
.
2019. INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease.. Neurology. 92(18):e2070-e2080.
.
2019. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.. Alzheimers Dement. 15(6):742-753.
.
2019. No apparent effect of naproxen on CSF markers of innate immune activation.. Ann Clin Transl Neurol. 6(6):1127-1133.
.
2019. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease.. Nat Commun. 10(1):4227.
.
2019. Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.. Pharmaceuticals (Basel). 12(1)
.
2019. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [F]THK5351 uptake in progressive supranuclear palsy.. Neuroimage Clin. 24:102091.
.
2019.